Oxford Cannabinoid Technologies Stock Operating Margin
| OCTHF Stock | USD 0 0.00 0.00% |
Oxford Cannabinoid Technologies fundamentals help investors to digest information that contributes to Oxford Cannabinoid's financial success or failures. It also enables traders to predict the movement of Oxford Pink Sheet. The fundamental analysis module provides a way to measure Oxford Cannabinoid's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Oxford Cannabinoid pink sheet.
Oxford |
Oxford Cannabinoid Technologies Company Operating Margin Analysis
Oxford Cannabinoid's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, Oxford Cannabinoid Technologies has an Operating Margin of 0.0%. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Biotechnology industry. The operating margin for all United States stocks is 100.0% lower than that of the firm.
Oxford Operating Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Oxford Cannabinoid's direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Oxford Cannabinoid could also be used in its relative valuation, which is a method of valuing Oxford Cannabinoid by comparing valuation metrics of similar companies.Oxford Cannabinoid is currently under evaluation in operating margin category among its peers.
Oxford Fundamentals
| Current Valuation | (3.87 M) | |||
| Shares Outstanding | 960.42 M | |||
| Shares Owned By Insiders | 44.08 % | |||
| Shares Owned By Institutions | 2.72 % | |||
| Price To Book | 0.41 X | |||
| Gross Profit | (3.15 M) | |||
| EBITDA | (5.63 M) | |||
| Book Value Per Share | 0.01 X | |||
| Market Capitalization | 11.9 M |
About Oxford Cannabinoid Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Oxford Cannabinoid Technologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Oxford Cannabinoid using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Oxford Cannabinoid Technologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Oxford Pink Sheet
Oxford Cannabinoid financial ratios help investors to determine whether Oxford Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Oxford with respect to the benefits of owning Oxford Cannabinoid security.